159 related articles for article (PubMed ID: 19617223)
1. Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease.
Chung AW; Yang HH; Sigrist MK; Brin G; Chum E; Gourlay WA; Levin A
Cardiovasc Res; 2009 Dec; 84(3):494-504. PubMed ID: 19617223
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease.
Chung AW; Yang HH; Kim JM; Sigrist MK; Chum E; Gourlay WA; Levin A
Circulation; 2009 Sep; 120(9):792-801. PubMed ID: 19687355
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in human type 2 diabetic arterial vasculature.
Chung AW; Hsiang YN; Matzke LA; McManus BM; van Breemen C; Okon EB
Circ Res; 2006 Jul; 99(2):140-8. PubMed ID: 16778129
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness.
Yasmin ; McEniery CM; Wallace S; Dakham Z; Pulsalkar P; Maki-Petaja K; Ashby MJ; Cockcroft JR; Wilkinson IB
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):372. PubMed ID: 15556929
[TBL] [Abstract][Full Text] [Related]
5. Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease.
Chang HR; Yang SF; Li ML; Lin CC; Hsieh YS; Lian JD
Clin Chim Acta; 2006 Apr; 366(1-2):243-8. PubMed ID: 16313894
[TBL] [Abstract][Full Text] [Related]
6. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
[TBL] [Abstract][Full Text] [Related]
7. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.
Tan J; Hua Q; Xing X; Wen J; Liu R; Yang Z
Hypertens Res; 2007 Oct; 30(10):959-63. PubMed ID: 18049028
[TBL] [Abstract][Full Text] [Related]
8. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
[TBL] [Abstract][Full Text] [Related]
9. Increased matrix metalloproteinase 2 activity in the human internal mammary artery is associated with ageing, hypertension, diabetes and kidney dysfunction.
Chung AW; Booth AD; Rose C; Thompson CR; Levin A; van Breemen C
J Vasc Res; 2008; 45(4):357-62. PubMed ID: 18332634
[TBL] [Abstract][Full Text] [Related]
10. Variation in the human matrix metalloproteinase-9 gene is associated with arterial stiffness in healthy individuals.
Yasmin ; McEniery CM; O'Shaughnessy KM; Harnett P; Arshad A; Wallace S; Maki-Petaja K; McDonnell B; Ashby MJ; Brown J; Cockcroft JR; Wilkinson IB
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1799-805. PubMed ID: 16709939
[TBL] [Abstract][Full Text] [Related]
11. EphA2 overexpression is associated with angiogenesis in ovarian cancer.
Lin YG; Han LY; Kamat AA; Merritt WM; Landen CN; Deavers MT; Fletcher MS; Urbauer DL; Kinch MS; Sood AK
Cancer; 2007 Jan; 109(2):332-40. PubMed ID: 17154180
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
Yasuda S; Miyazaki S; Kinoshita H; Nagaya N; Kanda M; Goto Y; Nonogi H
Clin Sci (Lond); 2007 Jan; 112(1):43-9. PubMed ID: 16939410
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.
Inoue K; Kamada M; Slaton JW; Fukata S; Yoshikawa C; Tamboli P; Dinney CP; Shuin T
Clin Cancer Res; 2002 Jun; 8(6):1863-70. PubMed ID: 12060629
[TBL] [Abstract][Full Text] [Related]
14. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases.
McLennan SV; Kelly DJ; Cox AJ; Cao Z; Lyons JG; Yue DK; Gilbert RE
Diabetologia; 2002 Feb; 45(2):268-75. PubMed ID: 11935159
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?
Peiskerová M; Kalousová M; Kratochvílová M; Dusilová-Sulková S; Uhrová J; Bandúr S; Malbohan IM; Zima T; Tesar V
Kidney Blood Press Res; 2009; 32(4):276-83. PubMed ID: 19797911
[TBL] [Abstract][Full Text] [Related]
16. Aging is associated with increased matrix metalloproteinase-2 activity in the human aorta.
McNulty M; Spiers P; McGovern E; Feely J
Am J Hypertens; 2005 Apr; 18(4 Pt 1):504-9. PubMed ID: 15831360
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of angiostatin in diabetic nephropathy.
Zhang SX; Wang JJ; Lu K; Mott R; Longeras R; Ma JX
J Am Soc Nephrol; 2006 Feb; 17(2):475-86. PubMed ID: 16394111
[TBL] [Abstract][Full Text] [Related]
18. Regional arterial stiffness in patients with type 2 diabetes and chronic kidney disease.
Kimoto E; Shoji T; Shinohara K; Hatsuda S; Mori K; Fukumoto S; Koyama H; Emoto M; Okuno Y; Nishizawa Y
J Am Soc Nephrol; 2006 Aug; 17(8):2245-52. PubMed ID: 16837632
[TBL] [Abstract][Full Text] [Related]
19. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.
Wang MC; Tsai WC; Chen JY; Huang JJ
Am J Kidney Dis; 2005 Mar; 45(3):494-501. PubMed ID: 15754271
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
